Literature DB >> 9293893

Bile duct epithelia as target cells in primary biliary cirrhosis and primary sclerosing cholangitis.

H P Dienes1, A W Lohse, G Gerken, P Schirmacher, H Gallati, H F Löhr, K H Meyer zum Büschenfelde.   

Abstract

Primary biliary cirrhosis (PBC) and primary sclerosing cholangitis (PSC) are chronic autoimmune-mediated diseases of the biliary tree, resulting in a loss of bile ducts. There are morphological features that clearly distinguish them from each other: in PBC, there is overt destruction of the bile ducts with disruption of the basement membrane; in PSC there is abundant periductular fibrosis with shrinkage and subsequent loss of the bile ducts. In order to see if the disparate histopathology is paralleled by different immunohistology we looked at a panel of epitopes on bile duct epithelia especially to see if biliary epithelial cells may present as targets for cell mediated immune response. In PBC bile duct epithelial cells mostly expressed CD58 (lymphocyte function-associated antigen 3), CD80 (B7 BB1), and CD95 (Fas). In PSC, however, these epitopes were only expressed in a few examples to a lower degree. The respective effector T lymphocytes were positive for CD2 and CD28. Subtyping of the lymphocytes in the liver tissue further showed a predominance of CD4 positive T cells over CD8 cells up to 2-to-1 in both diseases. Determination of lymphocytes by cytokines to Th1 or Th2 subtype showed a majority of Th1 lymphocytes in PBC and PSC. We conclude that in PBC bile duct epithelial cells may display features of target cells of a T cell-mediated immune reaction with the Th1 cells predominating. In PSC other mechanisms of bile duct loss may play a role, since in this disease the majority of cells lack essential epitopes that constitute targets of cell mediated immunity.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9293893     DOI: 10.1007/s004280050077

Source DB:  PubMed          Journal:  Virchows Arch        ISSN: 0945-6317            Impact factor:   4.064


  20 in total

Review 1.  Primary sclerosing cholangitis.

Authors:  S A Mitchell; R W Chapman
Journal:  Clin Rev Allergy Immunol       Date:  2000-04       Impact factor: 8.667

Review 2.  Autoimmune related pancreatitis.

Authors:  K Okazaki; T Chiba
Journal:  Gut       Date:  2002-07       Impact factor: 23.059

3.  Transgenic mice aberrantly expressing pyruvate dehydrogenase complex E2 component on biliary epithelial cells do not show primary biliary cirrhosis.

Authors:  K Inamura; H Tsuji; Y Nakamoto; M Suzuki; S Kaneko
Journal:  Clin Exp Immunol       Date:  2006-07       Impact factor: 4.330

Review 4.  Recent advances in autoimmune pancreatitis: concept, diagnosis, and pathogenesis.

Authors:  Kazuichi Okazaki; Kazushige Uchida; Toshiro Fukui
Journal:  J Gastroenterol       Date:  2008-07-04       Impact factor: 7.527

5.  Recent advances in autoimmune pancreatitis.

Authors:  Kazuichi Okazaki; Kazushige Uchida; Toshiro Fukui; Mitsunobu Matsushita; Makoto Takaoka
Journal:  Gastroenterol Hepatol (N Y)       Date:  2008-06

Review 6.  The coexistence of Sjögren's syndrome and primary biliary cirrhosis: a comprehensive review.

Authors:  Ying Sun; Weici Zhang; Baosen Li; Zhengsheng Zou; Carlo Selmi; M Eric Gershwin
Journal:  Clin Rev Allergy Immunol       Date:  2015-06       Impact factor: 8.667

Review 7.  Autoimmune pancreatitis--a new evolving pancreatic disease?

Authors:  Kazuichi Okazaki; Kazushige Uchida; Toshiro Fukui; Makoto Takaoka; Akiyoshi Nishio
Journal:  Langenbecks Arch Surg       Date:  2010-09-24       Impact factor: 3.445

Review 8.  Recent concepts of autoimmune pancreatitis and IgG4-related disease.

Authors:  Kazuichi Okazaki; Kazushige Uchida; Hideaki Miyoshi; Tsukasa Ikeura; Makoto Takaoka; Akiyoshi Nishio
Journal:  Clin Rev Allergy Immunol       Date:  2011-10       Impact factor: 8.667

Review 9.  Current management of primary sclerosing cholangitis in pediatric patients.

Authors:  Samar H Ibrahim; Keith D Lindor
Journal:  Paediatr Drugs       Date:  2011-04-01       Impact factor: 3.022

10.  Periductal interleukin-17 production in association with biliary innate immunity contributes to the pathogenesis of cholangiopathy in primary biliary cirrhosis.

Authors:  K Harada; S Shimoda; Y Sato; K Isse; H Ikeda; Y Nakanuma
Journal:  Clin Exp Immunol       Date:  2009-08       Impact factor: 4.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.